CERENIS THERAPEUTICS

Insiders Cerenis Therapeutics CINNOBER BOAT

Equities

0RAG

FR0012616852

Delayed CINNOBER BOAT Other stock markets			5-day change	1st Jan Change
- ^EUR	-.--%		-.--%	-.--%

03-14	Abionyx Pharma: to benefit from a 1ME grant from Bpifrance	CF
03-11	Abionyx: reduced net loss in 2023	CF

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Abionyx: former AbbVie executive appointed CMO	01-09	CF
ABIONYX Pharma Appoints Rob Scott as Chief Medical Officer and Head of R&D	01-08	CI
Abionyx: appointment of a chief digital & innovation officer	13/07/23	CF
Abionyx Pharma Names Digital, Innovation Chief	13/07/23	MT
Abionyx Pharma Names IRIS Pharma Founder as Chief Scientific Officer Amid Purchase Agreement	18/11/21	MT
ABIONYX Pharma : Announces a Named Patient Temporary Authorization for Use (ATUn) for CER-001 in France	08/01/20	BU
ABIONYX Pharma SA Announces Named Patient Temporary Authorization for Use for CER-001 in France	08/01/20	CI
ABIONYX Pharma SA Announces the Resignation of Barbara Yanni from Her Position as Member of the Board of Directors	03/01/20	CI
Cerenis Therapeteutics Holding will Change its Name to ABIONYX Pharma SA	16/09/19	CI
ABIONYX Pharma SA Announces Resignation of Richard Pasternak as Director and Chairman	13/09/19	CI
ABIONYX Pharma SA Announces Executive Changes	09/09/19	CI
Cerenis Therapeutics Holding SA will Change its Name to CERENIS Therapeutics	29/08/19	CI
ABIONYX Pharma Approves Appointment of Emmanuel Huynh as a Member of the Board	26/08/19	CI
Cerenis Therapeutics Holding SA Announces Executive Changes	19/12/18	CI
Cerenis Therapeutics Announces Appointment of Barbara Yanni to Board of Directors	07/08/18	CI
Cerenis Therapeutics Appoints Barbara Yanni as Independent Director	31/07/18	CI
Cerenis Therapeutics Holding SA Announces Appointment to Scientific Advisory Board	02/05/18	CI
Cerenis Therapeutics Announces Board Appointments	08/06/15	CI
Cerenis Therapeutics Announces Executive Changes	09/02/15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Rankings

More Top / Flop

Rankings

More Top / Flop

Currency / Forex

Commodities

Cryptocurrencies

Cryptocurrencies

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer